Posted to News on 25th Mar 2011, 00:00
Continuous monitoring in medical applications
Quality managers in plastics, electronics, nanotech, medical products and medical device companies can now obtain a guide to evaluating costs of monitoring critical environments while controlling risk factors from Veriteq, a Vaisala company.
Six different modalities used in medical device and medical products' materials and components industries for continuous monitoring - chart recorders, standalone data loggers, wired LAN networks with UPS backups, wired LAN networks using Power over Ethernet; WiFi; and Wireless Mesh - are systematically explained and compared in terms of costs of ownership and risks of non-compliance and loss in the context of today's regulatory environment.
Ken Appel, Manager of Regulated Industries for Veriteq, and author of the white paper explains that he wrote it to address the commonly overlooked sources of human error inherent in various monitoring modalities and to provide a systematic way for quality managers to weigh the pros and cons of different approaches to continuous monitoring.
Appel says: "Whether you choose one method over the other or a combination, you will have to decide what makes the most sense in your organization. There is no one solution that fits every situation.
"Always though, a concern is to address the level of risk you can afford, and to know what these risks are. Understandably, these decisions do not occur in a vacuum. Physical plant layout, existing IT infrastructure, support resources and management buy-in to name a few, will likely influence your path."
The white paper can be obtained by request by visiting Veriteq at www.veriteq.com/cost-ownership-med-dev/
